Comparative in vitro activity of telavancin, vancomycin and linezolid against heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA).

Comparative in vitro activity of telavancin, vancomycin and linezolid against heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA).

Item
http://www.wikidata.org/entity/Q45302467
Efficacy and safety of telavancin in clinical trials: a systematic review and meta-analysis.In Vitro Pharmacodynamics of Human Simulated Exposures of Telavancin against Methicillin-Susceptible and -Resistant Staphylococcus aureus with and without Prior Vancomycin Exposure.Evaluation of Pharmacodynamic Interactions Between Telavancin and Aztreonam or Piperacillin/Tazobactam Against Pseudomonas aeruginosa, Escherichia coli and Methicillin-Resistant Staphylococcus aureus.Efficacy of telavancin, a lipoglycopeptide antibiotic, in experimental models of Gram-positive infection.Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.Telavancin (VIBATIV) for the treatment of complicated skin and skin structure infections.Telavancin: the long and winding road from discovery to food and drug administration approvals and future directions.Lipoglycopeptide Antibacterial Agents in Gram-Positive Infections: A Comparative Review.Pharmacodynamics, pharmacokinetics and clinical efficacy of telavancin in the treatment of pneumonia.The ATTAIN trials: efficacy and safety of telavancin compared with vancomycin for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia.Baseline activity of telavancin against Gram-positive clinical isolates responsible for documented infections in U.S. hospitals (2011-2012) as determined by the revised susceptibility testing method.Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycin.
P2860

Comparative in vitro activity of telavancin, vancomycin and linezolid against heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA).

Item
http://www.wikidata.org/entity/Q45302467
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Comparative in vitro activity ...... Staphylococcus aureus (hVISA).
@en
Comparative in vitro activity ...... Staphylococcus aureus (hVISA).
@nl
type
label
Comparative in vitro activity ...... Staphylococcus aureus (hVISA).
@en
Comparative in vitro activity ...... Staphylococcus aureus (hVISA).
@nl
prefLabel
Comparative in vitro activity ...... Staphylococcus aureus (hVISA).
@en
Comparative in vitro activity ...... Staphylococcus aureus (hVISA).
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Comparative in vitro activity ...... Staphylococcus aureus (hVISA).
@en
P2093
P304
P31
P356
10.1016/J.IJANTIMICAG.2011.02.007
P433
P478
P577
P698